| Authors: |
Rieger I; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany., Tsintari V; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany., Overkamp M; Institute of Pathology at the University Hospital Tübingen, Tübingen, Germany., Fend F; Institute of Pathology at the University Hospital Tübingen, Tübingen, Germany., Lopez CD; Department of Hematology and Medical Oncology, Oregon Health and Science University (OHSU), Portland, OR, United States., Schittenhelm MM; Clinic of Medical Oncology and Hematology, Cantonal Hospital St. Gallen (KSSG), St. Gallen, Switzerland., Kampa-Schittenhelm KM; Department of Oncology, Hematology, Clinical Immunology and Rheumatology, University Hospital Tübingen (UKT), Tübingen, Germany.; Translational Experimental Hematology and Oncology, Medical Research Center and Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. |
